Oracle: Wedbush Says It’s the Next AI Infrastructure Winner
Oracle is seen as an AI cloud winner; Wedbush rates it “Outperform” with a $225 target, citing strong AI infrastructure and fast growth.
NOTRELOAD AI
JPMorgan Gives Hims & Hers a $35 Bullish Rating – Full GLP-1 Lineup Just Got Even Stronger
JPMorgan backs Hims & Hers Health as a strong buy, boosted by GLP-1 drugs and big deals with Novo Nordisk and Eli Lilly.
Cannabis Stocks Drop After Early Surge on Limited US Marijuana Rescheduling Move
Cannabis stocks fell after hype faded: US reform helps medical marijuana only, not full market, so investors took profits.
Intel Crushes Q1 2026 Earnings — AI CPU Demand Fuels Massive Q2 Beat
Intel beat Q1 2026 forecasts with strong AI chip demand, higher sales, and upbeat outlook as it works to catch up in AI race.
Regeneron Strikes Deal with Trump: Free Gene Therapy for Hearing Loss + Lower Drug Prices for Americans
Regeneron will cut U.S. drug prices, offer free gene therapy for hearing loss, and align costs with other countries under a Trump deal.
Skillz Wins $420 Million Verdict Against Papaya in Major Bot Fraud Lawsuit
Papaya Gaming must pay Skillz $420 million after a jury found it used bots to cheat players in human-only games.